Multiple mechanisms contribute to the development of clinically significant azole resistance in Aspergillus fumigatus

19Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.

Abstract

Infections caused by the filamentous fungus Aspergillus fumigatus are a significant clinical issue and represent the second most-common form of fungal infection. Azole drugs are effective against this pathogen but resistant isolates are being found more frequently. Infections associated with azole resistant A. fumigatus have a significantly increased mortality making understanding drug resistance in this organism a priority. The target of azole drugs is the lanosterol α-14 demethylase enzyme encoded by the cyp51A gene in A. fumigatus. Mutations in cyp51A have been described that give rise to azole resistance and been argued to be the primary, if not sole, contributor to azole resistance. Here, I discuss recent developments that indicate multiple mechanisms, including increased expression of ATP-binding cassette (ABC) transporter proteins, contribute to azole resistance. ABC transporters are well-established determinants of drug resistance in other fungal pathogens and seem likely to play a similar role in A. fumigatus.

Cite

CITATION STYLE

APA

Moye-Rowley, W. S. (2015). Multiple mechanisms contribute to the development of clinically significant azole resistance in Aspergillus fumigatus. Frontiers in Microbiology. Frontiers Media S.A. https://doi.org/10.3389/fmicb.2015.00070

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free